Xellia Pharmaceuticals is a specialty pharmaceutical company focused on providing important anti-infective treatments against serious and often life-threatening infections.
At Xellia Pharmaceuticals, they are highly skilled in the development and production of fermented and semi-synthetic small molecule based products.
Xellia Pharmaceuticals offers a range of Finished Dosage Form (FDF) products, primarily within the category of hospital injectables. Their portfolio of products contain some of the most important drugs used in the fight against infections with multi-drug resistant bacteria.
Gør som Xellia: Bliv certificeret